Dr Sanil Rege

July 25, 2022

Time to read: 17–20 minutes

When patients with Major Depressive Disorder (MDD) don’t respond to medication, clinicians have three options: Increase dose, switch or augment....

In this video, Dr Sanil Rege, Consultant Psychiatrist and Academic Lead of Psych Scene talks to Prof Ian Hickie and A/Prof Liz...

In this video Dr Sanil Rege, Consultant Psychiatrist covers the mechanism of action of Agomelatine. Agomelatine has recently been TGA approved fo...

Long-acting injectable antipsychotics (LAIs) are an effective treatment option in schizophrenia.  However, they are often viewed negatively by clinicia...

 Dr Sanil Rege

June 17, 2022

Time to read: 10 minutes

Brexpiprazole [7-{4-[4-(1-benzothiophene-4-yl) piperazin-1-yl]butoxy}quinolin-2(1H)-one] is a novel atypical antipsychotic that is structurally similar ...

 Dr Sanil Rege

June 9, 2022

Time to read: 8 minutes

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterised by inattention, disorganisation, and/or hyperactive impul...

 Dr Sanil Rege

June 3, 2022

Time to read: 4 minutes

Clozapine is metabolised in the liver predominantly by CYP1A2 and partially (35% ) by CYP3A4. It is, however, important to recognise that in some patien...

 Dr Sanil Rege

May 30, 2022

Time to read: 7 minutes

Lemborexant (DAYVIGO) is a dual orexin receptor antagonist (DORA) that was approved in 2019 for the treatment of sleep-onset and/or sleep maintenance in...

 Dr Sanil Rege

April 26, 2022

Time to read: 11–13 minutes

Lithium-induced nephropathy has been reported since the 1970s and covers many kidney function impairments. ...

 Dr Sanil Rege, Prof David Castle

April 7, 2022

Time to read: 21–25 minutes

Obesity is a critical public health problem predictive of the development of cardiovascular disease, metabolic syndrome,...